The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir

BACKGROUND: Currently available antiretroviral 2-drug regimen (2DR) fixed dose combinations may not be suitable for specific situations including the presence of resistance associated mutations (RAM) or drug − drug interactions (DDI). The data on the use of the non-nucleoside reverse transcriptase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sammet, Stefanie, Touzeau-Römer, Veronique, Wolf, Eva, Schenk-Westkamp, Pia, Romano, Birgit, Gersbacher, Elke, Kastenbauer, Ulrich, Boesecke, Christoph, Rockstroh, Jürgen, Scholten, Stefan, Schneeweiss, Stephan, Roider, Julia, Seybold, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665222/
https://www.ncbi.nlm.nih.gov/pubmed/37526898
http://dx.doi.org/10.1007/s15010-023-02075-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665222/
https://www.ncbi.nlm.nih.gov/pubmed/37526898
http://dx.doi.org/10.1007/s15010-023-02075-y

Ejemplares similares